HLN — Haleon plc

Healthcare • Drug Manufacturers - Specialty & Generic

$9.27

▲ 0.09 (—%)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Insider Activity Congress Trades Company Site ↗

Company

Ticker: HLN
Exchange
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: GB
CEO: Brian James McNamara
Employees: 24561
Website: www.haleon.com

Price

3M 1Y 5Y ALL

Showing 1Y history. Source: FMP “historical price full”.

Prev Close: $9.18
Day High: $9.32
Day Low: $9.19
52w High: $11.42
52w Low: $8.71
Volume: 9,702,194
Avg Volume
Beta: 0.229

Key Metrics

Market Cap: 42B
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available